We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SINV
10051
DELISTED
ETFMG Prime 2x Daily Inverse Junior Silver Miners ETF
SINV
$1K ﹤0.01%
93
-7
-7% -$83
GLSPW
10052
DELISTED
Global SPAC Partners Co. Warrants
GLSPW
$1K ﹤0.01%
+1,873
New +$644
LBPSW
10053
DELISTED
4D Pharma PLC Warrant
LBPSW
$1K ﹤0.01%
3,130
+1,810
+137% +$750
GGGVR
10054
DELISTED
G3 VRM Acquisition Corp. Rights
GGGVR
$1K ﹤0.01%
3,300
VFIN
10055
DELISTED
Simplify Volt Fintech Disruption ETF
VFIN
$1K ﹤0.01%
+220
New +$1.42K
BBLN.WS
10056
DELISTED
Babylon Holdings Limited Warrants, each exercisable for one Class A Ordinary Share
BBLN.WS
$1K ﹤0.01%
2,260
-100
-4% -$71
CALA
10057
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
108
-1,485
-93% -$15.2K
POTX
10058
DELISTED
Global X Cannabis ETF
POTX
$1K ﹤0.01%
+31
New +$968
TACA.WS
10059
DELISTED
Trepont Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordin
TACA.WS
$1K ﹤0.01%
7,455
+2,455
+49% +$722
CAS.WS
10060
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$1K ﹤0.01%
2,916
-974
-25% -$332
CMPI
10061
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$1K ﹤0.01%
183
-922
-83% -$2.65K
OCA.WS
10062
DELISTED
Omnichannel Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A comm
OCA.WS
$1K ﹤0.01%
5,439
-610
-10% -$208
OCA
10063
DELISTED
Omnichannel Acquisition Corp.
OCA
$1K ﹤0.01%
80
-510
-86% -$5.07K
OTRAW
10064
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$1K ﹤0.01%
5,415
-5,420
-50% -$1.87K
ARTAW
10065
DELISTED
Artisan Acquisition Corp. Warrants
ARTAW
$1K ﹤0.01%
2,896
+2,661
+1,132% +$1.19K
EVFM
10066
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1K ﹤0.01%
143
-4,674
-97% -$29.4K
KLDO
10067
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$1K ﹤0.01%
468
-10,750
-96% -$19.2K
LAIX
10068
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$1K ﹤0.01%
233
-1,112
-83% -$6.86K
CFRX
10069
DELISTED
ContraFect Corporation
CFRX
$1K ﹤0.01%
2
RSXJ
10070
DELISTED
VanEck Russia Small-Cap ETF
RSXJ
$1K ﹤0.01%
+69
New +$1.6K
ATIP
10071
DELISTED
ATI Physical Therapy, Inc.
ATIP
$1K ﹤0.01%
17
+5
+42% +$637
AILEW
10072
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$1K ﹤0.01%
+2,855
New +$975
NOVVU
10073
DELISTED
Nova Vision Acquisition Corp. Unit
NOVVU
$1K ﹤0.01%
56
-752
-93% -$7.73K
CHII
10074
DELISTED
Global X MSCI China Industrials ETF
CHII
$1K ﹤0.01%
47
-89
-65% -$1.4K
RCACU
10075
DELISTED
Revelstone Capital Acquisition Corp. Unit
RCACU
$1K ﹤0.01%
71
-1,313
-95% -$13K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.